Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL231884

DIOSMIN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O

Basic Information

ChEMBL ID CHEMBL231884
Name DIOSMIN
Phase Approved
Structure Type MOL
InChI Key GZSOSUNBTXMUFQ-YFAPSIMESA-N
Therapeutic ✓ Yes

Known Names

Barosmin Buchu resin Daflon Diosmetin 7-rutinoside Diosmin Diosmina Diosmine Diosven Dioven Diovenor Flebaven Flebavena +11 more
4
Targets
4
Activities
1
Assay Types
3
PK Parameters
20
Publications
23
Known Names
8
Indications
1
Mechanisms

Molecular Properties

608.5
MW (Da)
-1.09
ALogP
15
HBA
8
HBD
238.2
PSA (Ų)
0.16
QED
3
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Withdrawn
Chirality Single Enantiomer

Flags

Withdrawn Natural Product

Extended Properties

Molecular Formula C28H32O15
MW 608.55
Aromatic Rings 3
Heavy Atoms 43
NP-Likeness 1.78

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Unknown - -

Indications

Cardiovascular Diseases Arthritis, Rheumatoid Colitis, Ulcerative Non-alcoholic Fatty Liver Disease Peptic Ulcer Venous Insufficiency Infertility Menorrhagia

ATC Classification

C05CA03
diosmin
Level 1: CARDIOVASCULAR SYSTEM
Level 2: VASOPROTECTIVES
C05CA53
diosmin, combinations
Level 1: CARDIOVASCULAR SYSTEM
Level 2: VASOPROTECTIVES

Drug Warnings

Withdrawn
General Warning
unfavourable risk-benefit profile
Country: Spain   Year: 2002

Activity Summary

IC50 4 meas. best 5.41

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Inhibitor of nuclear factor kappa-B kinase subunit beta
CHEMBL1991
IC50 5.41 5.41 3890.0 1
Tumour suppressor protein p53/Mdm4
CHEMBL2221344
IC50 5.41 5.41 3890.0 1
Lysine-specific histone demethylase 1A
CHEMBL6136
IC50 4.99 4.99 10140.0 1
MDA-MB-231
CHEMBL400
IC50 4.16 4.16 70000.0 1

Pharmacokinetic Data

Parameter Value Units Species
Ka 1.84 10^4L/mol Bos taurus
Ka 0.88 10^4L/mol Bos taurus
Ka 0.19 10^4L/mol Bos taurus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
32083866 10.1021/acs.jnatprod.9b00887 Mus musculus 22
27374881 10.1016/j.bmc.2016.06.053 Albumin 14
31176093 10.1016/j.ejmech.2019.05.083 Mus musculus 13
18249545 10.1016/j.bmc.2008.01.028 No relevant target 5
27374881 10.1016/j.bmc.2016.06.053 SK-BR-3 4
27374881 10.1016/j.bmc.2016.06.053 MDA-MB-231 4
27374881 10.1016/j.bmc.2016.06.053 No relevant target 4
27374881 10.1016/j.bmc.2016.06.053 T47D 4
31176093 10.1016/j.ejmech.2019.05.083 Unchecked 3
20014752 10.1021/tx900326k Hepatotoxicity 3
31176093 10.1016/j.ejmech.2019.05.083 Tyrosine-protein phosphatase non-receptor type 1 3
27374881 10.1016/j.bmc.2016.06.053 A549 3
17166721 10.1016/j.bmc.2006.11.037 NON-PROTEIN TARGET 2
35033884 10.1016/j.bmc.2022.116614 No relevant target 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
33412152 10.1016/j.bmcl.2021.127775 C2C12 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
23249276 10.1021/np300460a No relevant target 2
32083866 10.1021/acs.jnatprod.9b00887 Transcription factor p65 2
18249545 10.1016/j.bmc.2008.01.028 Caco-2 2

Data from ChEMBL 36 via Core Engine